Losing two children inside a week and burying them side by side has been a terrible experience for the Gwizo family in Odzi.

The death of Tawanda and Knowledge due to muscular dystrophy represents the plight of people suffering from the rare disease which has no cure so far.

First it was Tawanda and before their tears had dried, the Gwizo family and the Odzi community was plunged back into mourning, after Knowledge the elder brother to Tawanda succumbed to duchene muscular dystrophy.

The rare disease has no cure and it has been medically proven that patients suffering from the genetic condition have a life span of up to 19 years.

The Gwizo children became pioneer residents at the Mt Olive Mission Hospital in Odzi, the only health facility being constructed by the District Outreach For Care And Support (DORCAS) to cater for patients suffering muscular dystrophy.

The death of Tawanda and Knowledge within a week has thrown a dark cloud on the family and the community.

With deep wounds and streams of tears, the Gwizo family has shifted its focus to their only surviving son, Learnmore who is now wheelchair-bound due to the same rare genetic condition.

DORCAS patron, Mrs Pennilope Mushohwe and voluntary care givers came in numbers to console the Gwizo family as they bade farewell to Knowledge.

Mr and Mrs Gwizo said the death of their two sons within a short space of time was a big blow.

DORCAS CEO, Reverend Togara Mapingure and care givers called for the government to come up with measures to assist patients suffering from the condition in accessing cheap drugs and other specialised health care services.

The care givers also highlighted that the children require specialised attention and treatment.

It is estimated that Zimbabwe is likely to have more than 3000 people suffering from Duchene Muscular Dystrophy (DMD), but only a fraction has come out in the open.

DMD is a genetic disorder characterised by progressive muscle degeneration and weakness, and the symptoms of weakness usually begins at the age of four.